Revised SPC: Sandostatin (octreotide) – all presentations

SPC includes a warning for cholangitis. Cases have been reported as a complication of cholelithiasis in in the post-marketing setting. Ultrasonic examination of the gallbladder before, and at about 6- to 12-month intervals during octreotide therapy are therefore recommended.

Source:

electronic Medicines compendium